GlassScriptPhysician profile
David B Minnick
NPI 1063616167
$5,968.53
in general payments reported to CMS, 2019-2025
13 companies · $1,353 in 2025
The $1,353 reported for 2025 was more than what 76% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,135 · 2020: $1,231 · 2022: $13.08 · 2023: $132 · 2024: $105 · 2025: $1,353.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,036 · Food and Beverage: $554.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,035.66 |
| Food and Beverage | $554.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $4,328.56 | 2019-2020 | |
| Stryker Corporation | $1,274.85 | 2025 | Chromophare F300, Mako |
| Smith+Nephew, INC. | $59.30 | 2023-2024 | Collagenase Santyl, Oasis, Grafix Pl |
| Takeda Pharmaceuticals U.S.A., INC. | $59.07 | 2025 | Gattex |
| Lifenet Health | $55.58 | 2023 | |
| Integra Lifesciences Corporation | $49.18 | 2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Melinta Therapeutics, LLC | $25.93 | 2019-2022 | |
| Heron Therapeutics, INC. | $24.80 | 2023 | Zynrelef |
| Abbvie INC. | $24.31 | 2019 | |
| Kerecis Limited | $19.63 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Davol INC. | $18.85 | 2025 | Arista |
| Hologic Sales and Service, LLC | $14.28 | 2023 | Coolseal Generator |
| Mesh Suture INC | $14.19 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Minnick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.